Mega Fine Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.53 Cr
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 48.00 Cr
- Satisfied Charges ₹ 48.75 Cr
- Revenue Growth 7.00%
- Profit Growth -7.66%
- Ebitda -10.91%
- Net Worth 15.36%
- Total Assets 7.43%
About Mega Fine Pharma
Mega Fine Pharma Private Limited (MFPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 August 1995 and has a history of 29 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.53 Cr.
The company currently has active open charges totaling ₹48.00 Cr. The company has closed loans amounting to ₹48.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Jhaveri, Shailesh Sanghvi, and Hasmukh Gandhi serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239MH1995PTC092028
- Company No.
092028
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Mega Fine Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Sanghvi  | Whole-Time Director | 22-Aug-1995 | Current |
| Ashok Jhaveri | Director | 05-Jun-2024 | Current |
| Hasmukh Gandhi | Whole-Time Director | 14-Apr-2000 | Current |
Financial Performance of Mega Fine Pharma.
Mega Fine Pharma Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7% increase. The company also saw a slight decrease in profitability, with a 7.66% decrease in profit. The company's net worth Soared by an impressive increase of 15.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mega Fine Pharma?
In 2024, Mega Fine Pharma had a promoter holding of 49.24% and a public holding of 50.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fhh Healthcare International Private LimitedAshok Jhaveri is a mutual person
- Aar Cube Enterprise Llp
Shailesh Sanghvi is a mutual person
- Jms Venture Llp
Shailesh Sanghvi is a mutual person
Charges (Loans)
Open Charges
₹48.00 Cr
Satisfied Charges
₹48.75 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 39.50 Cr
- Hdfc Bank Limited : 8.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 2012 | Hdfc Bank Limited | ₹8.50 Cr | Open |
| 13 Jun 2006 | State Bank Of India | ₹39.50 Cr | Open |
| 22 Nov 2019 | Hdfc Bank Limited | ₹44.50 Cr | Satisfied |
| 29 Sep 2003 | Canara Bank | ₹2.70 Cr | Satisfied |
| 05 Jun 2002 | Canara Bank | ₹0.80 M | Satisfied |
How Many Employees Work at Mega Fine Pharma?
Mega Fine Pharma has a workforce of 758 employees as of Dec 12, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mega Fine Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mega Fine Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Mega Fine Pharma
Recent activity within the organization
- Annual General Meeting
Mega Fine Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge registered on 22 Nov 2019 via Charge ID 100304683 with Hdfc Bank Limited was fully satisfied on 14 Aug 2024.
- Charges
A charge with Hdfc Bank Limited of Rs. 8.50 Cr registered on 26 Apr 2012 with Charge ID 10350830 was modified on 01 Aug 2024.
- Charges
A charge with State Bank Of India of Rs. 39.50 Cr registered on 13 Jun 2006 with Charge ID 10007239 was modified on 20 Jul 2024.
- Director Appointment
Ashok Kirtilal Jhaveri was appointed as a Director was appointed as a Director on 05 Jun 2024 & has been associated with this company since 9 months 2 days .
- Balance Sheet
Mega Fine Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Recent News, Updates & Announcement
- USFDA Issues Warning to Megafine Pharma Over Violations at Vapi Facility in Gujarat.
USFDA to Megafine Pharma: "Your Vapi facility in Gujarat has major violations of good manufacturing norms. You used bad materials and didn't clean equipment properly. Your test methods can't prove drug purity. Your quality system is not reliable. Fix everything or we won't approve your new drugs. Keep this up and we won't let your drugs into the US..
Frequently asked questions
What is the Incorporation or founding date of Mega Fine Pharma Private Limited?
Mega Fine Pharma Private Limited was incorporated on 22 Aug 1995.
What is authorized share capital and paid-up capital of Mega Fine Pharma Private Limited?
The authorized share capital of Mega Fine Pharma Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.53 Cr.
Who are the current board members & directors of Mega Fine Pharma Private Limited?
Currently 3 directors are associated with Mega Fine Pharma Private Limited.
- Ashok Kirtilal Jhaveri
- Shailesh Jethmal Sanghvi
- Hasmukh Purushottam Gandhi
What is the registered address of Mega Fine Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Mega Fine Pharma Private Limited is Sethna Building 4Th Floor 55 Maharshi Karve Road, Marine Lines India, Mumbai, Maharashtra, 400002.
What is the corporate identification number (CIN) and company number of Mega Fine Pharma Private Limited?
The corporate identification number (CIN) of Mega Fine Pharma Private Limited is U24239MH1995PTC092028 and the company number is 092028 as per Ministry of Corporate Affairs (MCA).
What is the official website of Mega Fine Pharma Private Limited?
The Official website of Mega Fine Pharma Private Limited is https://www.megafine.in
What has been the recent revenue trend for Mega Fine Pharma Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Mega Fine Pharma Private Limited has risen by 7.00%.
How many employees does Mega Fine Pharma Private Limited currently have?
As Per 2024 financial reports, 758 employees are currently employed by Mega Fine Pharma Private Limited.
What change has been observed in the net worth of Mega Fine Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Mega Fine Pharma Private Limited has experienced an upsurge of 15.36%.
What are the total open charges for Mega Fine Pharma Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Mega Fine Pharma Private Limited amount to ₹ 48.00 Cr.
When was the last Balance Sheet of Mega Fine Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Mega Fine Pharma Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
Kunal JhaveriDirector
Similar Companies Based on API Manufacturers
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Msn Laboratories Private Limited Rangareddy, Telangana, India
Lupin Limited Mumbai, Maharashtra, India
Ipca Laboratories Limited Mumbai, Maharashtra, India
Divi's Laboratories Limited Rangareddy, Telangana, India
Hetero Labs Limited Rangareddy, Telangana, India
Glenmark Pharmaceuticals Limited Mumbai, Maharashtra, India